Landis Homes
Lititz, Pennsylvania, 17543, United States
NCT Number: NCT01382693
This project, a small-scale pilot study, will attempt to determine if involvement in a group-based creative expression program may correlate with a reduction in use of psychotropic drugs for persons with dementia.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Lititz, Pennsylvania, 17543, United States
The study site has two skilled-nursing dementia Special Care Units. One unit will serve as a control with residents receiving the standard care activity program. The other unit will receive the standard care activity program as well as the TimeSlips storytelling program (two hour-long sessions per week for six weeks). The behavioral symptoms and psychotropic drug usage for both cohorts will be studied for eight months, the first four months with no intervention and the last four months with or without the six-week TimeSlips intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
TimeSlips is a group-based creative storytelling program for people with dementia. The intervention will be held twice a week for six weeks, in hour-long sessions.
Other names: creative expression program, storytelling program
Standard-of-care activities for the study site's skilled-nursing dementia Special Care Units.
Time frame: eight months
Time frame: eight months
Milton S. Hershey Medical Center
Other
Effects of Involvement in a Group-based Creative Expression Program on Psychotropic Drug Use in Persons With Dementia in Long-term Care: a Cluster-randomized Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05159869
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT05599100
Alzheimer Disease, Behavior
Seattle, Washington, United States
View Trial DetailsNCT03732521
Behavior, Behavioral Symptoms
Tortosa, Tarragona, Spain
View Trial DetailsNCT05814276
Behavior, Behavioral Symptoms
Morbio Inferiore, Switzerland
View Trial Details